Targeting late-stage non-small cell lung cancer with a combination of DNT cellular therapy and PD-1 checkpoint blockade

BACKGROUND: Though immune checkpoint blockade (ICB) against PD-1 has shown success in the treatment of lung cancer, not all patients respond. We have previously shown that adoptive transfer of double negative T (DNT) cells expanded from healthy donors can target leukemia but their role in treating e...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Linan, Ly, Dalam, Wang, Si-si, Lee, Jong Bok, Kang, Hyeonjeong, Xu, Hao, Yao, Junlin, Tsao, Ming-sound, Liu, Wei, Zhang, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6413451/
https://www.ncbi.nlm.nih.gov/pubmed/30857561
http://dx.doi.org/10.1186/s13046-019-1126-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6413451/
https://www.ncbi.nlm.nih.gov/pubmed/30857561
http://dx.doi.org/10.1186/s13046-019-1126-y

Ejemplares similares